Source: New York Times (Tuesday December 3, 2013)
Permalink: http://www.nytimes.com/2013/12/04/business/rare-cancer-treatments-cleared-by-fda-but-not-subject-to-scrutiny.html?pagewanted=1&_r=0&nl=todaysheadlines&adxnnl=1&emc=edit_th_20131204&adxnnlx=1386177634-AzIklli/2NDpyg6GfmnDhg